rss
J Clin Pathol 2009;62:289 doi:10.1136/jcp.2008.063834
  • Commentary

Stromal tumours: which diagnostic approach?

  1. G Bevilacqua
  1. Chairman, European Group for Molecular Pathology, ESP (European Society of Pathology); Director, Division of Surgical, Molecular and Ultrastructural Pathology, University of Pisa
  1. G Bevilacqua, Division of Surgical, Molecular and Ultrastructural Pathology, University of Pisa, Italy; g.bevilacqua{at}med.unipi.it
  • Accepted 10 December 2008
  • Published Online First 19 December 2008

Probably all pathologists agree that proliferations of stromal cells represent a somewhat complex chapter of pathology. In fact, their classification is still tentative, full of synonyms and with confusing terms, such as “inflammatory tumour” or “pseudosarcomatous proliferation”.

Several factors can contribute to this complexity: a possible common progenitor (fibrocyte)1 for fibroblasts and myofibroblasts; the fact that the fibrocyte can be considered as belonging to the leucocytes; the possible epithelial origin of mesenchymal cells (epithelial–mesenchymal transition); and the interconnections between physiological and pathological stromal proliferations.2

The absence of a satisfactory classification provided by …

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar